![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](hb6062contents.gif)
Acta Cryst. (2004). E60, m1066-m1067 [ doi:10.1107/S1600536804016009 ]
![[kappa]](/logos/entities/kappa_rmgif.gif)
N3)copper(II)]-![[mu]](/logos/entities/mu_rmgif.gif)
3-oxydiacetato]Abstract: In the title compound, [Cu(C4H4O5)(C7H6N2)]n, three oxydiacetate (ODA) dianions and one benzimidazole molecule coordinate to the CuII atom, resulting in an enlongated octahedral coordination geometry. Each ODA links three Cu atoms, chelating one and bridging two, forming a three-dimensional polymeric complex.
Online 9 July 2004
Copyright © International Union of Crystallography
IUCr Webmaster